<unk>  is a muscarinic antagonist that is FDA approved for the {{{indicationType}}} of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.   Common adverse reactions include constipation, dry mouth, headache, dyspepsia, nausea, urinary tract infection, accidental injury, and flu symptoms.
Darifenacin
Solifenacin
Arbekacin
Ioxaglic acid
Revefenacin
Calcifediol
Proglumetacin
Picloxydine